Yvonne Greenstreet
Directeur Général chez ALNYLAM PHARMACEUTICALS, INC.
Fortune : 10 M $ au 30/04/2024
Profil
Yvonne L. Greenstreet a fondé Highgate LLC. Actuellement, le Dr Greenstreet est présidente et chef de l'exploitation d'Alnylam Pharmaceuticals, Inc. Le Dr Greenstreet est également membre du conseil d'administration de Pacira Biosciences, Inc. et membre de l'Association de l'industrie pharmaceutique britannique. Auparavant, le Dr Greenstreet a occupé les postes de directeur général chez Highgate LLC, de premier vice-président et chef du développement des médicaments chez Pfizer Inc. et de chef de la stratégie de recherche et développement, premier vice-président chez GlaxoSmithKline Plc. Yvonne L. Greenstreet a obtenu un MBA de l'INSEAD et un diplôme de premier cycle de l'université de Leeds.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 72 289 ( 0,06% ) | 10 M $ | 30/04/2024 |
Postes actifs de Yvonne Greenstreet
| Sociétés | Poste | Début |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Directeur Général | 01/01/2022 |
The Association of the British Pharmaceutical Industry
 The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Anciens postes connus de Yvonne Greenstreet
| Sociétés | Poste | Fin |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 31/03/2023 |
| ARGENX SE | Directeur/Membre du Conseil | 03/03/2022 |
| INDIVIOR PLC | Directeur/Membre du Conseil | 31/03/2019 |
| MOELIS & COMPANY | Directeur/Membre du Conseil | 31/12/2018 |
Highgate LLC
 Highgate LLC Real Estate DevelopmentFinance Highgate LLC is a hospitality management and investing private company based in Birmingham, MI. Highgate LLC delivers market intelligence, scale, and technology to the hospitality industry. Highgate is known for its expertise in hotel management, investment, technology, and development, and has a diverse portfolio of hotels. The company was founded by Yvonne L. Greenstreet and Stephen R. Polk has been the CEO since 2013. | Directeur Général | 01/08/2016 |
Formation de Yvonne Greenstreet
| INSEAD | Masters Business Admin |
| University of Leeds | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| GSK PLC | Health Technology |
| PFIZER, INC. | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| INDIVIOR PLC | Health Technology |
| MOELIS & COMPANY | Finance |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ARGENX SE | Health Technology |
| Entreprise privées | 5 |
|---|---|
The Association of the British Pharmaceutical Industry
The Association of the British Pharmaceutical Industry Miscellaneous Commercial ServicesCommercial Services The Association of the British Pharmaceutical Industry is a non-profit organization, which engages in the research and development of medicines. It focuses on biosciences. The company is headquartered in London, the United Kingdom. | Commercial Services |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Molecular Insight Pharmaceuticals, Inc. engages in developing and commercializing innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose and treat disease. The company was founded in 1997 and the company is headquartered in Cambridge, MA. | Health Services |
Advanced Accelerator Applications SA
 Advanced Accelerator Applications SA Medical SpecialtiesHealth Technology Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Rueil-Malmaison Cedex, France. | Health Technology |
Highgate LLC
Highgate LLC Real Estate DevelopmentFinance Highgate LLC is a hospitality management and investing private company based in Birmingham, MI. Highgate LLC delivers market intelligence, scale, and technology to the hospitality industry. Highgate is known for its expertise in hotel management, investment, technology, and development, and has a diverse portfolio of hotels. The company was founded by Yvonne L. Greenstreet and Stephen R. Polk has been the CEO since 2013. | Finance |
| The American Funds Group | Miscellaneous |